IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells

IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells

A recent study showed that miR-26a is downregulated in hepatocellular carcinoma tissues and that this downregulation is an independent predictor of survival. Interestingly, the same study also reported that miR-26a downregulation causes a concomitant elevation of IL-6 expression. Beca...

Full description

Bibliographic Details
Main Authors:	Yafei Zhang, Bicheng Zhang, Anran Zhang, Xiaohua Li, Jian Liu, Jie Zhao, Yong Zhao, Jianfei Gao, Dianchun Fang, Zhiguo Rao
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2013-01-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	MiR-26a IL-6 c-Myc Hepatocellular carcinoma Carcinoma prognosis
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000100032&lng=en&tlng=en

Similar Items

by: Yafei Zhang, et al.
Published: (2013-01-01)

Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
by: Yafei Zhang, et al.
Published: (2012-09-01)

Effect and Mechanism of miR-26a-5p on Proliferation and Apoptosis of Hepatocellular Carcinoma Cells
by: Zhu WJ, et al.
Published: (2020-04-01)

miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2
by: Qiao Jin, et al.
Published: (2016-08-01)

Expressions of miR-96 and miR-103 in Hepatocellular Carcinoma and Their Correlation with Prognosis
by: XIAO Wei, et al.
Published: (2020-06-01)

Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection
by: Fei Ji, et al.
Published: (2018-04-01)

Effect of long non-coding RNA LINC00671 on biological behavior of hepatocellular carcinoma and its mechanism
by: GUO Tao, SONG Ning, SUN Yuqi, TIAN Jiaqi, TANG Jie, SUN Rongqi, JIANG Yingying
Published: (2022-10-01)

IL-32 and IL-34 in hepatocellular carcinoma
by: Yang Si, et al.
Published: (2022-11-01)

The Expression of Connexin 26 Regulates the Radiosensitivity of Hepatocellular Carcinoma Cells through a Mitogen-Activated Protein Kinases Signal Pathway
by: Yuan Li, et al.
Published: (2022-11-01)

MiR-26a Mediates Ultraviolet B-Induced Apoptosis by Targeting Histone Methyltransferase EZH2 Depending on Myc Expression
by: Ting Zhang, et al.
Published: (2017-10-01)

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
by: De-Ning Ma, et al.
Published: (2016-01-01)

circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506
by: Sun P, et al.
Published: (2020-01-01)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
by: Khalda S. Amr, et al.
Published: (2017-12-01)

lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma
by: Min Hu, et al.
Published: (2020-01-01)

<i>c-Myc</i> Acts as a Competing Endogenous RNA to Sponge <i>miR-34a</i>, in the Upregulation of CD44, in Urothelial Carcinoma
by: Pie-Che Chen, et al.
Published: (2019-09-01)

Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
by: Feng L, et al.
Published: (2024-02-01)

A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma
by: Yan Mei, et al.
Published: (2020-01-01)

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway
by: Hua Li, et al.
Published: (2019-07-01)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
by: Jun Zhang, et al.
Published: (2021-11-01)

Down‐regulation of miR‐26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1
by: Lei Shi, et al.
Published: (2016-12-01)

PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition
by: Yang Yang, et al.
Published: (2022-03-01)

LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3
by: Gege Shu, et al.
Published: (2021-01-01)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
by: Kangdi Xu, et al.
Published: (2022-12-01)

MiR-376a and Histone Deacetylation 9 Form A Regulatory Circuitry in Hepatocellular Carcinoma
by: Yongxia Zheng, et al.
Published: (2015-01-01)

Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis
by: Anqi Wu, et al.
Published: (2020-08-01)

Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
by: He Wang, et al.
Published: (2021-06-01)

Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
by: Nannan Zhang, et al.
Published: (2019-12-01)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
by: Qinglei Kong, et al.
Published: (2019-04-01)

Cordycepin inhibits colon cancer proliferation by suppressing MYC expression
by: Zhe Zhang, et al.
Published: (2022-02-01)

miR-26a/b Inhibit Tumor Growth and Angiogenesis by Targeting the HGF-VEGF Axis in Gastric Carcinoma
by: Yiran Si, et al.
Published: (2017-07-01)

Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis
by: Dan Liu, et al.
Published: (2021-01-01)

MiR‐559 targets GP73 to suppress proliferation and invasion of hepatocellular carcinoma in vitro
by: Xue‐Song Zheng, et al.
Published: (2020-10-01)

A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population
by: Moqin Qiu, et al.
Published: (2020-10-01)

Converged DNA Damage Response Renders Human Hepatocellular Carcinoma Sensitive to CDK7 Inhibition
by: Guiqin Xie, et al.
Published: (2022-03-01)

LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma
by: Nuobei Zhang, et al.
Published: (2021-11-01)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
by: Yue Meng, et al.
Published: (2018-03-01)

LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c
by: Shuai Xue, et al.
Published: (2021-04-01)

Circ_0091579 enhances the malignancy of hepatocellular carcinoma via miR-1287/PDK2 axis
by: Shu Junwei, et al.
Published: (2021-01-01)

Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
by: LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan
Published: (2023-08-01)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction]
by: Li F, et al.
Published: (2023-04-01)